- Sector: Health Technology
- Industry: Pharmaceuticals: Other
Halo Labs, Inc. engages in the development and manufacture of cannabis oils and concentrates. Its operations include Oregon, Nevada, and California. The company was founded in 2016 and is headquartered in Toronto, Canada.
TORONTO, Jan. 15, 2021 /CNW/ – Halo Labs Inc. (“Halo” or the “Company“) (NEO: HALO) (OTCQX: AGEEF) (Germany: A9KN) is pleased to provide updates on recent developments with respect to Bophelo Bioscience & Wellness (Pty) Ltd. (“Bophelo“) in Lesotho, South Africa and MedCan Ltd., the Company’s Malta offtake partner (“MedCan“). Bophelo continues to operate during the COVID-19 pandemic with special approval from the […]
All figures in USD and as per BDS Analytics, Inc. unless stated otherwise TORONTO, Jan. 12, 2021 /CNW/ – Halo Labs Inc. (“Halo” or the “Company“) (NEO: HALO) (OTCQX: AGEEF) (Germany: A9KN) announces that BDS Analytics, Inc. (“BDSA”) has reported record year over year retail sales growth in November 2020 of Halo products in Oregon’s recreational cannabis market. Oregon retail sales reached $89.9 million in November […]
TORONTO, Dec. 30, 2020 /CNW/ – Halo Labs Inc. (“Halo” or the “Company“) (NEO: HALO) (OTCQX: AGEEF) (Germany: A9KN) is pleased to announce it has closed its previously announced acquisition of 1275111 B.C. Ltd. (“1275111“) on the terms described in the press release dated December 22, 2020 (the “Transaction“). Halo issued an aggregate of 147,475,343 common shares of Halo (“Halo Shares“) […]
Something went wrong. Please refresh the page and/or try again.